A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity? Preprint
GHDx Entry last modified on: May 12, 2022
Disease outbreaks
Dataset Records for Disease outbreaks
Displaying 1 - 50 of 831
Federal Ministry of Health Implements Massive Distribution of Personal Protective Equipment to Primary Healthcare Centres in Nigeria
GHDx Entry last modified on: May 12, 2022
Presence of antibodies to SARS-CoV-2 in Sweden, 26 April - 9 May 2021
Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021
Survey:
Epi surveillance
Andhra Pradesh: '59% found to have Covid antibodies in sero-survey'
Survey:
Epi surveillance
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Sep 13, 2022
[Seroprevalence to SARS-CoV-2 among the population of the Belgorod Region amid the COVID-19 epidemic]
GHDx Entry last modified on: Mar 14, 2022
Portugal National Serological Survey COVID-19 (2nd phase) 2021
Inquérito Serológico Nacional COVID-19 (2.ª fase) (INS COVID-19)
Survey:
Individual
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase
Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.
Survey:
Epi surveillance
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors
Antistoffen coronavirus bij gemiddeld 18,6% van de donors
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey
Survey:
Epi surveillance
United States COVID-19 Data Tracker Vaccinations 2021-2022
CDC COVID Data Tracker
Administrative data:
Epi surveillance
COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada. Preprint.
GHDx Entry last modified on: Nov 5, 2021
Zimbabwe COVID-19 Daily Update 2021
GHDx Entry last modified on: Dec 22, 2022
Bhutan Royal Centre for Disease Control Quarterly Bulletin: First Quarter, Volume 25, January-March 2021
RCDC 1st Quarterly Bulletin Volume 25, Jan -March 2021
Epi surveillance:
Subnationally representative
Yemen Supreme National Emergency Committee for COVID-19 Daily Report 2021
GHDx Entry last modified on: Dec 16, 2022
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Brazil - Tocantins COVID-19 Epidemiological Bulletin 2021
Boletim Epidemiológico Notificação para COVID-19 2021
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.1.7
GHDx Entry last modified on: Sep 9, 2022
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
United States COVID Tracking Project 2021
The COVID Tracking Project at The Atlantic
Canada - Ontario Daily Epidemiological Summary of COVID-19 2021
Epidemiologic Summary COVID-19 in Ontario
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.351
GHDx Entry last modified on: Sep 9, 2022
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint
GHDx Entry last modified on: Mar 14, 2022
India COVID-19 Crowdsourced Patient Database: Vaccine Doses Administered by State
GHDx Entry last modified on: Nov 15, 2022
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: B.1.525
GHDx Entry last modified on: Sep 9, 2022
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Genomic Overview of SARS-CoV-2 in Denmark, Lineages and Mutations of Interest: P.1
GHDx Entry last modified on: Sep 9, 2022
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
Covid-19 Vaccination Strategy In Spain 2020-2022
Estrategia De Vacunación Covid-19 En Espana
Italy Open Data on COVID-19 Vaccines 2020-2022
covid19-opendata-vaccini, Open Data su consegna e somministrazione dei vaccini anti COVID-19 in Italia
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
Australia Household Impacts of Covid-19 Survey November 2020
Survey:
Longitudinal
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Canada - British Columbia COVID-19 Situation Report 2020-2022
British Columbia (BC) COVID-19 Situation Report
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
India - Haryana Covid-19 Sero Survey Round 2, October 2020
Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)
Survey:
Cross-sectional - Epi surveillance - Urban-rural representative
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Subscribe